December 25, 2008

Takeda Pharmaceutical Company Limited

Notice of Execution of Acquisition of the Company’s Own Shares

Osaka, Japan, December 25, 2008 --- Takeda Pharmaceutical Company Limited (“Takeda”) announced today that it completed acquisition of its own shares in the market, which was resolved by its Board of Directors on November 26, 2008.

1. Class of shares acquired:	Shares of common stock
2. Total number of shares acquired:	10,885,800 shares
3. Total value of acquisition:	Yen 48,703,896,000
4. Period of acquisition:	From November 27, 2008 to December 22, 2008
5. Method of acquisition:	Purchased on the Tokyo Stock Exchange

(Reference)

Resolution of the Board of Directors on November 26, 2008

1. Class of shares to be acquired:	Shares of common stock
2. Number of shares to be acquired:	Up to 11 million shares (equivalent to 1.35% of the total issued shares)
3. Total amount of shares to be acquired:	Up to 50 billion Yen
4. Schedule of acquisition:	From November 27, 2008 to December 22, 2008

Treasury shares held by Takeda as of December 22, 2008

1. Aggregate number of issued shares:     (excluding treasury shares)	789,448,230 shares
2. Number of treasury shares:	25,704,165 shares

# # #